These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


287 related items for PubMed ID: 2060724

  • 1. Effect of linogliride on hormone release from perfused rat pancreas. Fuel dependence and desensitization by tolbutamide.
    Ronner P, Cheong E, Khalid P, Tuman RW, Matschinsky FM.
    Diabetes; 1991 Jul; 40(7):878-84. PubMed ID: 2060724
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of ATP-sensitive K+ channels in pancreatic beta-cells by nonsulfonylurea drug linogliride.
    Ronner P, Higgins TJ, Kimmich GA.
    Diabetes; 1991 Jul; 40(7):885-92. PubMed ID: 2060725
    [Abstract] [Full Text] [Related]

  • 3. Influence of the oral hypoglycemic agent linogliride (McN-3935) on insulin secretion from isolated rat islets of Langerhans.
    Zawalich WS, Rasmussen G, Tuman RW, Tutwiler GF.
    Endocrinology; 1987 Mar; 120(3):880-5. PubMed ID: 3542516
    [Abstract] [Full Text] [Related]

  • 4. Effect of tolbutamide on insulin, glucagon, and somatostatin release from the diabetic rat pancreas with special reference to glucose concentration.
    Kadowaki S, Taminato T, Chiba T, Nozawa M, Fujita T, Norman AW.
    Endocrinology; 1983 Jun; 112(6):2187-92. PubMed ID: 6133743
    [Abstract] [Full Text] [Related]

  • 5. Therapeutical concentrations of tolbutamide, glibenclamide, gliclazide and gliquidone at different glucose levels: in vitro effects on pancreatic A- and B-cell function.
    Gregorio F, Ambrosi F, Cristallini S, Pedetti M, Filipponi P, Santeusanio F.
    Diabetes Res Clin Pract; 1992 Dec; 18(3):197-206. PubMed ID: 1289021
    [Abstract] [Full Text] [Related]

  • 6. Somatostatin, insulin and glucagon secretion by the perfused pancreas from the cysteamine-treated rat.
    Silvestre RA, Miralles P, Moreno P, Villanueva ML, Marco J.
    Biochem Biophys Res Commun; 1986 Feb 13; 134(3):1291-7. PubMed ID: 2868720
    [Abstract] [Full Text] [Related]

  • 7. In vitro effect of exogenous insulin on insulin secretion. Studies with glucose, leucine, arginine, aminophylline and tolbutamide.
    Verspohl EJ, Händel M, Hagenloh I, Ammon HP.
    Acta Diabetol Lat; 1982 Feb 13; 19(4):303-17. PubMed ID: 6758458
    [Abstract] [Full Text] [Related]

  • 8. The effect of hydrocortisone treatment and adrenalectomy on insulin and glucagon secretion from the perfused rat pancreas.
    Lenzen S.
    Endokrinologie; 1976 Feb 13; 68(2):189-97. PubMed ID: 795635
    [Abstract] [Full Text] [Related]

  • 9. Adaptations of alpha2- and beta-cells of rat and mouse pancreatic islets to starvation, to refeeding after starvation, and to obesity.
    Matschinsky FM, Rujanavech C, Pagliara A, Norfleet WT.
    J Clin Invest; 1980 Jan 13; 65(1):207-18. PubMed ID: 6985616
    [Abstract] [Full Text] [Related]

  • 10. Glucagon secretion from the isolated perfused rat pancreas: influenced by the glucose-, tolbutamide- and pancreozymin-mediated release of pancreatic insulin.
    Fussgänger RD, Goberna R, Laube H, Schröder KE, Straub K, Pfeiffer EF.
    Isr J Med Sci; 1972 Jun 13; 8(6):768-9. PubMed ID: 4559419
    [No Abstract] [Full Text] [Related]

  • 11. Effects of tolbutamide on insulin and glucagon secretion of the isolated perfused rat pancreas.
    Laube H, Fussgänger R, Goberna R, Schröder K, Straub K, Sussman K, Pfeiffer EF.
    Horm Metab Res; 1971 Jul 13; 3(4):238-42. PubMed ID: 4256979
    [No Abstract] [Full Text] [Related]

  • 12. Effect of tolbutamide on aminophylline-, 3,5-AMP-dibutyrate- or glucagon-induced insulin release from pancreatic islets after impairment of pyridine nucleotide metabolism caused by 6-aminonicotinamide (6-AN).
    Ammon HP.
    Naunyn Schmiedebergs Arch Pharmacol; 1975 Jul 13; 290(2-3):251-64. PubMed ID: 241943
    [Abstract] [Full Text] [Related]

  • 13. A different action of hypothermia on insulin release from the isolated, perfused rat pancreas, depending on the stimulating agent.
    Loubatieres-Mariani MM, Chapa J, Puech R, Manteghetti M.
    Diabetes; 1980 Nov 13; 29(11):895-8. PubMed ID: 7000586
    [Abstract] [Full Text] [Related]

  • 14. Glucose modulates the amount, but not the kinetics, of insulin released by sulfonylureas.
    Gregorio F, Ambrosi F, Filipponi P, Cristallini S, Santeusanio F.
    J Diabetes Complications; 1994 Nov 13; 8(4):204-12. PubMed ID: 7833495
    [Abstract] [Full Text] [Related]

  • 15. [Regulation of insulin release in perifused pancreatic tissue].
    Burr IM, Renold AE, Stauffacher W, Grodsky GM, Balant L.
    Acta Diabetol Lat; 1969 Sep 13; 6 Suppl 1():580-96. PubMed ID: 4906025
    [No Abstract] [Full Text] [Related]

  • 16. Sulfonylurea compounds uncouple the glucose dependence of the insulinotropic effect of glucagon-like peptide 1.
    de Heer J, Holst JJ.
    Diabetes; 2007 Feb 13; 56(2):438-43. PubMed ID: 17259389
    [Abstract] [Full Text] [Related]

  • 17. Insulin release by tolbutamide and glibenclamide. A comparative study on the perfused rat pancreas.
    Joost HG, Hasselblatt A.
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Apr 13; 306(3):185-8. PubMed ID: 112482
    [Abstract] [Full Text] [Related]

  • 18. [Effect of adenosine triphosphate (ATP) on the secretion of insulin induced by tolbutamide in the absence of glucose].
    Chapal J, Roye M, Loubatières-Mariani MM.
    C R Seances Soc Biol Fil; 1980 Apr 13; 173(6):1120-3. PubMed ID: 6446366
    [Abstract] [Full Text] [Related]

  • 19. Glucose modulation of amino acid-induced glucagon and insulin release in the isolated perfused rat pancreas.
    Pagliara AS, Stillings SN, Hover B, Martin DM, Matschinsky FM.
    J Clin Invest; 1974 Oct 13; 54(4):819-32. PubMed ID: 4430716
    [Abstract] [Full Text] [Related]

  • 20. Dynamics of insulin and glucagon secretion by the isolated perfused cat pancreas.
    Curry DL, Morris JG, Rogers QR, Stern JS.
    Comp Biochem Physiol A Comp Physiol; 1982 Oct 13; 72(2):333-8. PubMed ID: 6125307
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.